Zhengye Biotechnology Holding (ZYBT) Equity Ratio: 2023-2024
- Zhengye Biotechnology Holding's Equity Ratio rose 5.31% to 0.71 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.71, marking a year-over-year increase of 5.31%. This contributed to the annual value of 0.70 for FY2024, which is 3.67% up from last year.
- According to the latest figures from Q4 2024, Zhengye Biotechnology Holding's Equity Ratio is 0.71, which was up 5.31% from 0.68 recorded in Q4 2023.
- Zhengye Biotechnology Holding's 5-year Equity Ratio high stood at 0.71 for Q4 2024, and its period low was 0.68 during Q4 2023.
- Moreover, its 2-year median value for Equity Ratio was 0.70 (2024), whereas its average is 0.70.
- Data for Zhengye Biotechnology Holding's Equity Ratio shows a peak YoY climbed of 5.31% (in 2024) over the last 5 years.
- Zhengye Biotechnology Holding's Equity Ratio (Quarterly) stood at 0.68 in 2023, then rose by 5.31% to 0.71 in 2024.
